n.a. (IN)

10.00
0.01 0.10
NYSE
Prev Close 10.01
Open 10.01
Day Low/High 9.99 / 10.01
52 Wk Low/High 6.02 / 10.36
Volume 1.95M
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

Lupin Bolsters US Brands Portfolio With Methergine® Oral Tablets

Lupin Bolsters US Brands Portfolio With Methergine® Oral Tablets

Product to Address Rising Incidence of Postpartum Hemorrhage in the US

Lupin Launches Generic Intermezzo® Sublingual Tablets In The US

Lupin Launches Generic Intermezzo® Sublingual Tablets In The US

1st product launch from the GAVIS pipeline with 180 days exclusivity

Lupin Acquires Biocom In Russia

Lupin Acquires Biocom In Russia

InMed Pharmaceuticals Qualifies For Electronic Trading In The U.S.

InMed Pharmaceuticals Qualifies For Electronic Trading In The U.S.

-- Company Now Eligible for Depository Services Through DTC --

Lupin Launches Zaxine® In Canada

Lupin Launches Zaxine® In Canada

InMed Expands Pipeline With Initiation Of Program Targeting Epidermolysis Bullosa Simplex (EBS)

InMed Expands Pipeline With Initiation Of Program Targeting Epidermolysis Bullosa Simplex (EBS)

Pre-clinical studies of INM-750 to commence February, 2015

KKR Extends Financing To GMR Holdings

KKR Extends Financing To GMR Holdings

Leading global investment firm KKR announced that it has signed a term sheet to provide INR10 billion (US$164.

Lupin Inks Strategic Joint Venture Agreement With Yoshindo Inc.

Lupin Inks Strategic Joint Venture Agreement With Yoshindo Inc.

New Entity YL Biologics to focus on clinical development and commercialization of Biosimilars for Japan